Investor Relations Home

Homepage > MEDTOX Info > Investors > Investor Relations Home

Webcast
Q4 2009 MEDTOX Scientific, Inc. Earnings Conference Call (Live)
02/10/10 at 9:30 a.m. CT

Profile

MEDTOX Scientific, Inc. is engaged throughout the United States in two distinct, but related businesses - forensic and clinical laboratory services to corporations, pharmaceutical companies and health care organizations (the Laboratory segment), and the manufacturing and distribution of diagnostic drug screening devices (the Diagnostic segment).

Featured Report

2008 Annual Report

Stock Quote

MTOX (Common Stock)
Exchange	NASDAQ GS (US Dollar)
Price	$8.48
Change (%)	0.13 (1.56%)
Volume	22,900
Data as of 02/09/10 4:00 p.m. ET Minimum 20 minute delay Refresh quote

Recent News

More >>

Date	Title
02/03/10	MEDTOX Scientific Announces Fourth Quarter and Year-End Conference Call
10/14/09	MEDTOX Scientific Announces Third Quarter Results
10/07/09	MEDTOX Scientific Announces Third Quarter Conference Call
07/29/09	MEDTOX Scientific Receives FDA 510(k) Clearance for Additional Three Drugs On the PROFILE(r)-V MEDTOXScan(r) Drugs-of-Abuse Test System

Contact Information

Primary IR Contact

Investor Relations
Phone: 877-715-7236
E-mail: investors@medtox.com

Accountants

Deloitte & Touche, LLP
400 One Financial Plaza
120 South Sixth Street
Minneapolis, MN 55402

Transfer Agent

American Stock Transfer & Trust Company
59 Maiden Lane
3rd Floor
New York, NY 10038
Phone: 800-937-5449
E-mail: info@amstock.com

Legal

Fredrikson & Byron
200 South Sixth Street
Minneapolis, MN 55402

Copyright © 2008 MarketWatch, Inc. All rights reserved. Please see our Terms of Use.
Designed and powered by Dow Jones Client Solutions
Intraday data provided by Interactive Data Real Time Services and subject to the Terms of Use.
Intraday data is at least 20-minutes delayed. All times are ET.
Historical and current end-of-day data provided by Interactive Data Pricing and Reference Data.